Although a full characterization of each of the components of the regulon is beyond the scope of this work, it is reasonable to consider the possibility that in future studies many of CELF1's downstream targets will be found to be similarly misexpressed at only the protein level in primary human breast cancers. This evidence concerns the gene CELF1 and breast cancer.